Pancreatic Safety of Sitagliptin in the TECOS Study von Buse, John B, Bethel, M Angelyn, Green, Jennifer B, Stevens, Susanna R, Lokhnygina, Yuliya, Aschner, Pablo, Grado, Carlos Raffo, Tankova, Tsvetalina, Wainstein, Julio, Josse, Robert, Lachin, John M, Engel, Samuel S, Patel, Keyur, Peterson, Eric D, Holman, Rury R

Volltext

Effect of Sitagliptin on Kidney Function and Respective Cardiovascular Outcomes in Type 2 Diabetes: Outcomes From TECOS von Cornel, Jan H, Bakris, George L, Stevens, Susanna R, Alvarsson, Michael, Bax, Willem A, Chuang, Lee-Ming, Engel, Samuel S, Lopes, Renato D, McGuire, Darren K, Riefflin, Axel, Rodbard, Helena Wachslicht, Sinay, Isaac, Tankova, Tsvetalina, Wainstein, Julio, Peterson, Eric D, Holman, Rury R

Volltext

Secondary Prevention of Cardiovascular Disease in Patients With Type 2 Diabetes Mellitus: International Insights From the TECOS Trial (Trial Evaluating Cardiovascular Outcomes With Sitagliptin) von Pagidipati, Neha J, Navar, Ann Marie, Pieper, Karen S, Green, Jennifer B, Bethel, M Angelyn, Armstrong, Paul W, Josse, Robert G, McGuire, Darren K, Lokhnygina, Yuliya, Cornel, Jan H, Halvorsen, Sigrun, Strandberg, Timo E, Delibasi, Tuncay, Holman, Rury R, Peterson, Eric D

Volltext

Association of obesity with cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease: Insights from TECOS von Pagidipati, Neha J., Zheng, Yinggan, Green, Jennifer B., McGuire, Darren K., Mentz, Robert J., Shah, Svati, Aschner, Pablo, Delibasi, Tuncay, Rodbard, Helena W., Westerhout, Cynthia M., Holman, Rury R., Peterson, Eric D.

Volltext

Sitagliptin and risk of fractures in type 2 diabetes: Results from the TECOS trial von Josse, Robert G., Majumdar, Sumit R., Zheng, Yinggan, Adler, Amanda, Bethel, M. Angelyn, Buse, John B., Green, Jennifer B., Kaufman, Keith D., Rodbard, Helena W., Tankova, Tsvetalina, Westerhout, Cynthia M., Peterson, Eric D., Holman, Rury R., Armstrong, Paul W.

Volltext

Assessing the Safety of Sitagliptin in Older Participants in the Trial Evaluating Cardiovascular Outcomes with Sitagliptin (TECOS) von Bethel, M Angelyn, Engel, Samuel S, Green, Jennifer B, Huang, Zhen, Josse, Robert G, Kaufman, Keith D, Standl, Eberhard, Suryawanshi, Shailaja, Van de Werf, Frans, McGuire, Darren K, Peterson, Eric D, Holman, Rury R

Volltext

Increased Risk of Severe Hypoglycemic Events Before and After Cardiovascular Outcomes in TECOS Suggests an At-Risk Type 2 Diabetes Frail Patient Phenotype von Standl, Eberhard, Stevens, Susanna R, Armstrong, Paul W, Buse, John B, Chan, Juliana C N, Green, Jennifer B, Lachin, John M, Scheen, Andre, Travert, Florence, Van de Werf, Frans, Peterson, Eric D, Holman, Rury R

Volltext

Causes of Death in a Contemporary Cohort of Patients With Type 2 Diabetes and Atherosclerotic Cardiovascular Disease: Insights From the TECOS Trial von Sharma, Abhinav, Green, Jennifer B, Dunning, Allison, Lokhnygina, Yuliya, Al-Khatib, Sana M, Lopes, Renato D, Buse, John B, Lachin, John M, Van de Werf, Frans, Armstrong, Paul W, Kaufman, Keith D, Standl, Eberhard, Chan, Juliana C N, Distiller, Larry A, Scott, Russell, Peterson, Eric D, Holman, Rury R

Volltext

Rationale, design, and organization of a randomized, controlled Trial Evaluating Cardiovascular Outcomes with Sitagliptin (TECOS) in patients with type 2 diabetes and established cardiovascular disease von Green, Jennifer B., MD, Bethel, M. Angelyn, MD, Paul, Sanjoy K., PhD, Ring, Arne, PhD, Kaufman, Keith D., MD, Shapiro, Deborah R., DrPH, Califf, Robert M., MD, Holman, Rury R., MB, ChB, FRCP

Volltext

Sex differences in management and outcomes of patients with type 2 diabetes and cardiovascular disease: A report from TECOS von Alfredsson, Joakim, Green, Jennifer B., Stevens, Susanna R., Reed, Shelby D., Armstrong, Paul W., Angelyn Bethel, M., Engel, Samuel S., McGuire, Darren K., Van de Werf, Frans, Hramiak, Irene, White, Harvey D., Peterson, Eric D., Holman, Rury R.

Volltext

Safety of sitagliptin in patients with type 2 diabetes and chronic kidney disease: outcomes from TECOS von Engel, Samuel S., Suryawanshi, Shailaja, Stevens, Susanna R., Josse, Robert G., Cornel, Jan H., Jakuboniene, Neli, Riefflin, Axel, Tankova, Tsvetalina, Wainstein, Julio, Peterson, Eric D., Holman, Rury R.

Volltext

Cardiovascular Event Hazards over Time in TECOS von Bethel, M Angelyn, Sourij, Harald, Stevens, Susanna R, Lokhnygina, Yuliya, Lopes, Renato D, Adler, Amanda, Mcguire, Darren K, Peterson, Eric, Holman, Rury R

Volltext

Re‐adjudication of the Trial Evaluating Cardiovascular Outcomes with Sitagliptin (TECOS) with study‐level meta‐analysis of hospitalization for heart failure from cardiovascular outcomes trials with dipeptidyl peptidase‐4 (DPP‐4) inhibitors von Scirica, Benjamin M., Im, KyungAh, Murphy, Sabina A., Kuder, Julia F., Rodriguez, Dolly A., Lopes, Renato D., Green, Jennifer B., Ruff, Christian T., Sabatine, Marc S.

Volltext

Association between glycated haemoglobin levels and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease: a secondary analysis of the TECOS randomized clinical trial von McAlister, Finlay A., Zheng, Yinggan, Westerhout, Cynthia M., Buse, John B., Standl, Eberhard, McGuire, Darren K., Van de Werf, Frans, Green, Jennifer B., Armstrong, Paul W., Holman, Rury R.

Volltext

Effect of race on the glycaemic response to sitagliptin: Insights from the Trial Evaluating Cardiovascular Outcomes with Sitagliptin (TECOS) von Davis, Timothy M. E., Mulder, Hillary, Lokhnygina, Yuliya, Aschner, Pablo, Chuang, Lee‐Ming, Raffo Grado, Carlos A., Standl, Eberhard, Peterson, Eric D., Holman, Rury R.

Volltext

TECO: A Unified Feature Map Compression Framework Based on Transform and Entropy von Shi, Yubo, Wang, Meiqi, Cao, Tianyu, Lin, Jun, Wang, Zhongfeng

Volltext

International variation in characteristics and clinical outcomes of patients with type 2 diabetes and heart failure: Insights from TECOS von Bhatt, Ankeet S., Luo, Nancy, Solomon, Nicole, Pagidipati, Neha J., Ambrosio, Giuseppe, Green, Jennifer B., McGuire, Darren K., Standl, Eberhard, Cornel, Jan H., Halvorsen, Sigrun, Lopes, Renato D., White, Harvey D., Holman, Rury R., Peterson, Eric D., Mentz, Robert J.

Volltext

Progression of glucose‐lowering diabetes therapy in TECOS von Bethel, M. Angelyn, Engel, Samuel S., Stevens, Susanna R., Lokhnygina, Yuliya, Ding, Jie, Josse, Robert G., Alvarsson, Michael, Hramiak, Irene, Green, Jennifer B., Peterson, Eric D., Holman, Rury R.

Volltext

Low-density lipoprotein cholesterol treatment and outcomes in patients with type 2 diabetes and established cardiovascular disease: Insights from TECOS von De Ferrari, Gaetano M., Stevens, Susanna R., Ambrosio, Giuseppe, Leonardi, Sergio, Armstrong, Paul W., Green, Jennifer B., Wamil, Malgorzata, Holman, Rury R., Peterson, Eric D.

Volltext

Abstract 15589: Mitochondrial Metabolites Predict Cardiovascular Outcomes and Heart Failure in People With Type 2 Diabetes Mellitus and Vascular Disease: A Tecos Substudy von Regan, Jessica A, Green, Jennifer, Truby, Lauren K, Nguyen, Maggie, Giamberardino, Stephanie, Mentz, Robert J, McGarrah, Robert W, Zheng, Yinggan, Buse, John B, McGuire, Darren K, standl, eberhard, Armstrong, Paul W, Holman, Rury R, Peterson, Eric D, Shah, Svati H

Volltext